# Oxaliplatin-induced Portal Hypertension

> **NCT04524676** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Gastroesophageal Varices Hemorrhage
- Colorectal Cancer
- Received Oxaliplatin-based Chemotherapy

## Interventions

- **PROCEDURE:** Individualized Treatment

## Key facts

- **NCT ID:** NCT04524676
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-31
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524676, "Oxaliplatin-induced Portal Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04524676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*